Skip to content

The Family-ICU Trial

Family Participation in Intensive Care Unit Rounds (The Family-ICU Trial)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06586541
Acronym
Family-ICU
Enrollment
194
Registered
2024-09-19
Start date
2024-11-18
Completion date
2029-07-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Intensive Care, Family-centered Care, Family Engagement, Health Care Delivery, Patient and Family Engagement, Physician Rounds

Keywords

Patient- and Family-Centered, Patient- and Family-Centered Care, Family Engagement, Critical Care, Intensive Care Unit, Person-Centered Care, Delivery of Health Care, Family Participation in Rounds, Physician Rounds

Brief summary

Family inclusion in adult intensive care unit (ICU) rounds is recommended by critical care professional societies, yet widespread uptake of this practice is limited. A key barrier cited by ICU clinicians is insufficient evidence to support this practice. There is a need for robust evidence to support family participation in adult ICU rounds and influence change to routine clinical care. The primary purpose of this study is to assess whether family participation in adult ICU rounds improves family engagement in care. The secondary objectives are to assess family satisfaction, and anxiety and depression, to explore user experiences of family participation in ICU rounds, and to evaluate strategies to improve family member recruitment and retention rates. This is a stepped-wedge cluster randomized trial (n=194) at 6 Canadian ICUs. The stepped wedge cluster randomized trial is a pragmatic study design that overcomes methodological limitations in evaluating a healthcare service delivery intervention. In the stepped-wedge cluster design, there is random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed. The stepped-wedge design also allows each site to function as its own control. The stepped-wedge design is more powerful than a parallel design when substantial cluster level effects are present.

Interventions

OTHERParticipation in attending team rounds

Family members participate in-person. If the family member wishes to participate in-person, they will be invited to be present when the team rounds in the ICU.

Sponsors

Lady Davis Institute
Lead SponsorOTHER
Canadian Institutes of Health Research (CIHR)
CollaboratorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult family members (age ≥ 18 years) of ICU patients * Expected ICU stay ≥ 48 hours

Exclusion criteria

* Family members who do not wish to participate in care * Repeat admissions within the study period * Another family member has already participated in the study

Design outcomes

Primary

MeasureTime frameDescription
FAMily Engagement (FAME) score within 1 week of ICU discharge1-week post-hospital dischargeThe FAMily Engagement (FAME) tool is a self-administered 12-item questionnaire that assesses an individual's current engagement practice. FAME uses a five-point Likert scale ranging from 1 (strongly agree) to 5 (strongly disagree), and scale results are changed to a 0-100 scoring system, with higher scores indicating greater engagement in care. The following subdomains are evaluated: engagement perception, family presence, communication, education, decision-making, care contribution, and family needs. FAME includes the following engagement domains: family presence, family needs, communication and education, decision making, and direct care. FAME also captures the following family-centered care principles: dignity and respect, information sharing, participation, and collaboration.
Quality of communication (QOC score)1-week post-hospital dischargeThe Quality of Communication tool is a 13-item questionnaire that was developed and validated in an ICU setting to measure the perceived quality of communication. Scores range from 0 to 100, with higher scores indicating better clinician-family communication.

Secondary

MeasureTime frameDescription
Anxiety and depression (HADS)6 months post-hospital dischargeThe Hospital Anxiety and Depression Scale (HADS) is a simple to use, validated, and widely used self-reported tool to measure anxiety and depression in medical patients. The survey is composed of 14 questions: 7 depression-related and 7 anxiety-related questions. The score for each item ranges from 0 to 3, and subscale scores greater than 8 denotes anxiety or depression.
Post-traumatic stress (IES-Revised)6 months post-hospital dischargeThe IES-Revised is a 22-item questionnaire that has been validated and is widely used for measuring post-traumatic stress symptoms and yields a total score ranging from 0 to 88 and subscale scores for the Intrusion, Avoidance, and Hyperarousal subscales. Items are rated on a 5-point scale ranging from 0 (not at all) to 4 (extremely). High scores indicate greater severity of PTSD.
Family satisfaction in the ICU (FS-ICU)1-week post-hospital dischargeThe Family Satisfaction in the ICU survey (FS-ICU) is a 24-item instrument that was developed and validated to assess family satisfaction and experience with care in the ICU. Scores range from 0 to 100, with higher scores indicate greater satisfaction.
Quality of life (EuroQOL-5D-5L score)6 months post-hospital dischargeThe EuroQOL-5D-5L is a 5-item questionnaire that has been validated and is widely used for measuring health-related quality of life. Each dimension has five response levels: no problems (Level 1); slight; moderate; severe; and extreme problems (Level 5). The scores are combined to generate a single index value for overall health status. EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state

Countries

Canada

Contacts

CONTACTKabisan Vilvaratnam
kabisan.vilvaratnam.ccomtl@ssss.gouv.qc.ca5143408222
PRINCIPAL_INVESTIGATORMichael J Goldfarb, MD, MSc

Lady Davis Institute, McGill University, Jewish General Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026